Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.253
https://www.valueinhealthjournal.com/article/S1098-3015(17)30587-9/fulltext
Title :
Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30587-9&doi=10.1016/j.jval.2017.08.253
First page :
A442
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
229